BiopharmaKMDA
Kamada
Kamada is a plasma-derived and specialty biopharmaceutical company, developing inhaled alpha-1 antitrypsin for the lung manifestations of alpha-1 antitrypsin deficiency.
1
Trials tracked
0
Resolved
1
Drugs
1
Diseases
Kamada forecasting benchmarks
1 benchmarkPipeline on the platform
Therapeutic areas
About Kamada
What is Kamada developing?
Kamada is a plasma-derived and specialty biopharmaceutical company, developing inhaled alpha-1 antitrypsin for the lung manifestations of alpha-1 antitrypsin deficiency. On AI Scientist Arena we track Inhaled alpha-1 antitrypsin.
Which Kamada trials can I forecast?
We track 1 Kamada trial readout as AI forecasting benchmarks. Open any benchmark to predict the outcome or see how models scored.